Search Login Register

Photopheresis Summary

Description: A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen (METHOXSALEN) and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases.

Also Known As: Extracorporeal Photochemotherapies; Photochemotherapies, Extracorporeal; Photopheresis, Extracorporeal; Extracorporeal Photochemotherapy; Extracorporeal Photopheresis Show All >>

Networked: 509 relevant articles (88 outcomes, 51 trials/studies) for this Therapy

Key Diseases for which Photopheresis is Relevant

  1. Graft vs Host Disease (Graft-Versus-Host Disease) : 31 outcomes 11 studies in 173 results
  2. Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) : 26 outcomes 10 studies in 172 results
  3. Autoimmune Diseases (Autoimmune Disease) : 8 outcomes 2 studies in 33 results
  4. Sezary Syndrome (Sezary Erythroderma) : 5 outcomes 1 study in 12 results
  5. Systemic Scleroderma (Systemic Sclerosis) : 4 outcomes 8 studies in 31 results
Show All >>

Drugs Related to Photopheresis

  1. Interferon-alpha (Interferon Alfa)
  2. Tacrolimus (Prograf)
  3. Methoxsalen (Oxsoralen)
  4. Immunosuppressive Agents (Immunosuppressants)
  5. Psoralens
  6. Azithromycin (Zithromax)
  7. Steroids
  8. Immunoglobulin G (IgG)
  9. Dihydrotachysterol (AT 10)
  10. vorinostat (suberoylanilide hydroxamic acid)
Show All >>

Therapies Related to Photopheresis

  1. Photopheresis
  2. Homologous Transplantation (Allograft)
  3. Transplants (Transplant)
  4. Immunomodulation
  5. Stem Cell Transplantation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.